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OBJECTIVE — To assess the utility of a point-of-care (POC) capillary blood glucose mea-
surement as compared with routine clinical parameters in predicting undiagnosed diabetes in a
low-resource rural India setting.
RESEARCH DESIGN AND METHODS — Nine hundred and ninety-four participants
aged 30 years and stratiﬁed by age and sex were randomly selected from 20 villages in India.
A clinical questionnaire, sampling for laboratory venous fasting plasma glucose (FPG), and POC
capillary blood glucose assay were performed simultaneously. Diabetes diagnosis was based on
the World Health Organization (WHO) deﬁnition using FPG. The capacity of the POC glucose
topredictthepresenceofdiabeteswasassessedandcomparedwiththequestionnaireusingarea
under the receiver operating characteristic curves (AUCs).
RESULTS — The AUC for POC glucose alone in predicting diabetes was 0.869 (95% CI
0.810–0.929). This was signiﬁcantly better (P  0.001 for AUC comparison) than the models
based upon clinical variables alone (AUC for the best clinical model including age, BMI, hyper-
tension, waist circumference: 0.694 [95% CI 0.621–0.766]). POC glucose appropriately reclas-
siﬁed the risk of up to one-third of participants ranked according to the clinical models. Adding
the clinical variables to the POC glucose assay did not signiﬁcantly improve the discriminatory
capability beyond that achieved with the POC glucose measurement alone (all P  0.37).
CONCLUSIONS — POC glucose testing appears to be a simple and reliable tool for identi-
fying undiagnosed diabetes in a high-risk, resource-poor rural population. However, studies
evaluating the cost effectiveness of introducing POC glucose testing are needed prior to wide-
spread implementation.
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T
he prevalence of type 2 diabetes is
rapidly increasing around the world
(1). Developing countries are facing
the largest increases both in absolute and
relative terms (1). It is predicted that this
will have devastating consequences on
theeconomiesandhealthsystemsofthese
countries. Successful prevention and
early management of diabetes is therefore
a major health priority (1,2).
In many regions, up to 50% of people
with diabetes remain undiagnosed (1,3,4).
Failure to improve these levels of detection
will mean that the opportunity to improve
health outcomes with early intervention
will be lost. Early treatment with successful
glucose control signiﬁcantly reduces the
morbidity and mortality associated with di-
abetes (5,6). Earlier detection of diabetes
also allows for the implementation of other
treatments that reduce the vascular compli-
cations of diabetes (5,6).
Universalscreeningfordiabetesisnot
currently recommended due to a lack of
good evidence for an accurate test. How-
ever, targeted screening is advocated in
certain ethnic groups deemed at in-
creasedriskofdiabetes(2).Forsomeeth-
nic groups, implementation of targeted
screening may require the entire popula-
tion to be screened. This applies for in-
stancetoAsianIndianpopulations,which
are at greater risk of developing diabetes
(7)andhaveahighprevalenceofdiabetes
both in urban (4) and rural settings (3).
However to successfully apply screening
to such populations requires accurate,
safe, and low-cost diagnostic strategies
that are easy to implement (8).
In resource-poor settings, clinical
variables–based risk assessment ques-
tionnaires or point-of-care (POC) glucose
analysis may be reasonable screening
tools (9). Both require little expertise and
allow an individual’s risk of having undi-
agnoseddiabetestobeimmediatelydeter-
mined so that only those at high risk
require a conﬁrmatory diagnostic test.
However, the value of risk assessment
questionnaires (9–13) and POC glucose
analysis (14–16) in resource-poor set-
tings remains unclear. Additionally the
performance of these different screening
methods has not been compared in rural
Asian Indian populations.
The aim of this study was to quantify
and compare the accuracy of strategies
based on POC glucose, clinical variables,
andthecombinationofbothinpredicting
undiagnosed diabetes in an asymptom-
atic, resource-poor rural Asian Indian
population.
RESEARCH DESIGN AND
METHODS— This study was con-
ducted as part of the Andhra Pradesh Ru-
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brief, 20 villages (total population
75,089) were selected from the East and
West Godavari regions that were broadly
representativeofthesetwodistrictsonthe
basisoftheirpopulationsizeanddistance
from the nearest large town. The Byrraju
Foundation(alocalnongovernmentorga-
nization committed to improving rural
health) had recently conducted a popula-
tion census in these 20 villages with data
collection on individuals’ age, sex, and
contactdetails.Thisenabledarandomse-
lectionofarepresentativesampleof1,085
participants (aged 30 years) for this
study based on age and sex stratiﬁcation.
The study was approved by the ethics
committeesoftheCAREHospital,Hyder-
abad in India, and the University of Syd-
ney in Australia.
Baseline assessment
The survey was conducted in 2005.
Trained staff administered a structured
questionnaire, performed a brief physical
examination, and laboratory tests. The
questionnaire included questions relating
to demographic and socioeconomic char-
acteristics, personal and family histories,
and lifestyle. Physical examination in-
cluded measurements of blood pressure
and anthropometric variables. Known
cardiovascular disease was based on self-
reportedhistoryofheartattack,angina,or
stroke. Diagnosis of hypertension was
based on self-reported history of hyper-
tension, use of blood pressure-lowering
medications, or an average of two blood
pressure recordings 140 mmHg (sys-
tolic) and/or 90 mmHg (diastolic).
The laboratory assessments included
a fasting (8 h) capillary POC ﬁnger-
prick glucose analysis and fasting venous
blood glucose and lipid measurements.
Fastingcapillaryplasmaglucosewasmea-
sured using B. Braun USV meters (Mel-
sungen, Germany). Venous blood
samples collected in the villages were im-
mediately refrigerated and transferred on
ice to the ﬁeld laboratory within4ho f
collection for separation, glucose analy-
sis, and freezing at 20°C. Venous
plasma glucose assessment used the glu-
cose oxidase peroxidase method. Frozen
samples were transferred to a central in-
ternationally accredited laboratory in the
CARE Hospital, Hyderabad, where cho-
lesterol and subfractions were analyzed.
Participants with a history of diabetes
(self-reported history of doctor-
diagnosed diabetes or self-reported cur-
rent pharmacological diabetes control
treatments) were excluded from the anal-
ysis. Newly diagnosed diabetes was de-
ﬁnedaccordingtothe1999WorldHealth
Organization (WHO) criteria and was
based on the fasting venous glucose sam-
ple being 7 mmol/l (18).
Statistical analysis
Data were analyzed with SAS/STAT ver-
sion9.2(SASInstitute,Cary,NC).Results
were reported as percentages and mean
(SD or median [interquartile range]). The
concordance between venous plasma and
POC glucose measurements was assessed
with the Pearson correlation coefﬁcient.
Systematic bias in the two measurements
at any given level of blood glucose was
examined using Bland and Altman plots
(19). Logistic regressions were used to as-
sess the association between POC capil-
lary glucose, clinical prediction models
(using two diabetes risk scores developed
in urban India [9,13]), and the presence
of new diabetes. The area under the re-
ceiver operating characteristic curve
(AUC) then assessed and compared the
abilityofthePOCglucose,clinicalpredic-
tion models, and the combination of both
to predict the presence of diabetes (20).
This was complemented with the calcula-
tion of the integrated discrimination im-
provement (IDI) statistic (21). The
performance of POC glucose and the two
Indian diabetes scores was further as-
sessed at different thresholds for deﬁning
the high risk of undiagnosed diabetes
(i.e., POC glucose [mmol/l] 5 vs. 5;
5.6 vs. 5.6; 6.1 vs. 6.1; 7 vs.
7)andtherecommendedthresholdsfor
the Indian risk scores (i.e., Mohan’s score
60 vs. 60; Ramachandran’s score
21 vs. 21) (9,13). The net reclassiﬁ-
cation improvement (21) was then used
to evaluate risk reclassiﬁcation with the
use of POC glucose in participants with
and without diabetes within Indian risk
score categories.
RESULTS
Baseline proﬁle of participants with
and without diabetes
Ofthe1,085participantsinitiallystudied,
91 participants were excluded: 90 with
previously diagnosed diabetes and 1 with
missingdataforBMIandwaistcircumfer-
ence leaving a total of 994 participants
(51% women). Of the 994 participants,
45 (4.5%) had undiagnosed diabetes
based on elevated fasting venous plasma
glucose. Table 1 summarizes the charac-
Table 1—Baseline characteristics of the study participants (n  994)
Variables
Newly diagnosed diabetes based
on fasting venous glucose
P Yes No
n 45 949
Age (years) 53 (13) 48 (14) 0.03
Men (%) 20 (44.4) 464 (48.9) 0.67
Family history of diabetes* (n %) 6 (13.3) 91 (9.6) 0.41
Hypertension† (n %) 13 (29.5) 163 (17.2) 0.04
History of cardiovascular disease‡ (n %) 2 (4.5%) 63 (6.6%) 0.99
BMI (kg/m
2) 23.5 (5) 21.8 (4.2) 0.01
Waist circumference (cm) 84 (11) 78 (11) 0.001
Waist-to-hip ratio 0.90 (0.06) 0.87 (0.07) 0.02
Systolic blood pressure (mmHg) 130 (23) 123 (20) 0.02
Diastolic blood pressure (mmHg) 81 (12) 76 (11) 0.01
Fasting venous blood glucose (mmol/l) 9.2 (3.5) 5.2 (0.7) 0.001
Fasting POC blood glucose (mmol/l) 8.8 (4.3) 5.5 (0.9) 0.001
Total cholesterol (mmol/l) 5.0 (1.1) 4.7 (1.2) 0.04
LDL cholesterol (mmol/l) 3.1 (1) 2.9 (0.9) 0.13
HDL cholesterol (mmol/l) 1.2 (0.2) 1.2 (0.3) 0.93
Triglycerides (mmol/l) 1.12 (0.8–1.6) 1.11 (0.81–1.6) 0.21
Use of lipid-lowering therapy* 0 6 (0.6%) 1.0
Use of aspirin* 0 21 (2.2%) 0.63
Dataarereportedasmean(SD),number(%),ormedian(interquartilerange).*Self-reported.†Hypertension
diagnosis if self-reported prior diagnosis of hypertension from their doctor, self-reported use of prescription
medicationsforhypertension,iftheyhadasystolicbloodpressure(basedon2visits)140mmHg,orifthey
had a diastolic blood pressure (based on 2 visits) 90 mmHg. ‡Cardiac disease if self-reported prior
diagnosis of heart attack, angina, or stroke from their doctor.
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whethertheydidordidnothavediabetes.
Agreement between POC capillary
and venous plasma glucose analysis
There was a high positive correlation be-
tween POC capillary and venous plasma
glucosevalues(r0.76,P0.001)(Fig.
1A). On Bland and Altman plots, there
was no evidence of systematic bias in the
two measurements at any given blood
glucose level (Fig. 1B). The prevalence of
undiagnosed diabetes increased from
0.3% in the lower stratum of POC capil-
lary glucose (POC glucose 5 mmol/l) to
63% in the upper stratum (POC glu-
cose  8 mmol/l) (Fig. 1D). Of all those
with undiagnosed diabetes, 20% had a
POC capillary glucose value of 6
mmol/l.
Clinical predictors of diabetes versus
POC capillary glucose
Unadjusted estimates of the association be-
tween clinical variables, POC capillary glu-
cose, and the presence of undiagnosed
diabetes are shown in supplementary Table
1, available in an online appendix at http://
care.diabetesjournals.org/cgi/content/full/
dc10-1270/DC1. Age, hypertension, blood
pressure variables, BMI, waist circumfer-
ence, hip circumference, waist-to-hip ratio,
and POC capillary glucose were all signiﬁ-
cantly associated with undiagnosed diabe-
tes. Sex, family history of diabetes, and
physicalactivitywerenotsigniﬁcantlyasso-
ciated with undiagnosed diabetes.
The discriminatory power of POC
capillary glucose for predicting the pres-
ence of diabetes was very good with an
AUC of 0.869 (95% CI 0.810–0.929)
overall (Fig. 1C), 0.884 (0.795–0.975) in
men, 0.861 (0.780–0.942) in women,
and 0.796 (0.571–1.000), 0.996 (0.913–
0.999), 0.822 (0.661–0.984), and 0.839
(0.732–0.945) in the age-groups 30–39,
40–49, 50–59, and 60 years, respec-
tively. When the POC capillary glucose
wascomparedwitheachofthesigniﬁcant
individual clinical variables, its discrimi-
natory power for predicting undiagnosed
diabetes was always better (supplemen-
tary Table 1). Among those without dia-
betes (based on venous glucose; 949
participants),thediscriminatorypowerof
POCglucoseforpredictingimpairedfast-
ing glycemia (venous plasma glucose:
6.1to7.0mmol/l)was0.716(0.656–
0.773). The AUC for the prediction of
both diabetes and impaired fasting glu-
cose was 0.768 (0.722–0.815) overall,
Figure 1—Concordance between laboratory venous blood glucose analysis and POC glucose analysis. A: Pearson correlation and scatter plot (n 
994). B: Differences vs. means plot (Bland and Altman plot) of fasting capillary blood glucose measured by POC glucose testing (B. Braun) glucose
meter and the venous laboratory glucose measurement. The horizontal top and bottom line represent  2 SD. C: Discriminatory power of POC
glucose in predicting undiagnosed diabetes (participants were categorized as diabetics and nondiabetics based on fasting venous blood glucose
measurement).D:Prevalenceofundiagnoseddiabetes(basedonlaboratoryvenousglucoseanalysis)instratadeﬁnedbyPOCcapillarybloodglucose
level.
Screening for type 2 diabetes
46 DIABETES CARE, VOLUME 34, NUMBER 1, JANUARY 2011 care.diabetesjournals.org0.736 (0.665–0.806) in men, and 0.801
(0.742–0.860) in women.
The performance of the prediction
models is shown in Table 2. The AUC
(95% CI) for the Indian risk scores were
0.662 (0.581–0.743) and 0.678 (0.597–
0.759), respectively. These were signiﬁ-
cantly lower than that for POC glucose
alone (all P  0.0001). Similarly, other
clinicalmodelsdevelopedfromthesedata
never performed as well as POC glucose
alone. The basic clinical model (model 1)
included age, BMI, and hypertension. Al-
ternative models also included one of fol-
lowing: waist circumference, hip
circumference, or waist-to-hip ratio. For
thesenewclinicalmodels,thehighestdis-
criminatory power was achieved with the
combination of model 1 and waist cir-
cumference (AUC 0.694 [CI 95% 0.621–
0.766]).WhenPOCcapillaryglucosewas
added to this model, the AUC signiﬁ-
cantly increased to 0.867 (0.803–0.932)
(P  0.0001 for the difference in AUC).
However when the performance of this
model was compared with that of POC
capillary glucose alone, there was no sig-
niﬁcant difference between the two in
predicting diabetes (P  0.89). Similarly,
adding POC glucose to any of our new
clinical models did not increase the AUC
beyond that of the POC glucose alone
(Table 2). Based on the IDI statistics (Ta-
ble2),addingPOCglucosetoeitherofthe
Indian diabetes scores did not improve
modelsbeyondPOCglucosealone.How-
ever a signiﬁcant increase in the IDI from
1.63 to 1.74 (all P  0.04) was observed
when POC glucose was added to the
newly developed clinical models. This in-
dicates a marginal enhancement in the
discriminatory capabilities of the models
using POC and clinical variables instead
of POC alone.
Theperformanceoftheclinicalscores
and POC glucose at prespeciﬁed thresh-
olds is shown in supplementary Table 2.
As expected, the sensitivity and negative
predictive value of POC capillary glucose
for diagnosing diabetes diminished at
higher glucose level cutoffs, while the
speciﬁcity and positive predictive value
increased.Performancemeasureswereal-
waysbetterforPOCglucosethanforclin-
ical scores. At each of the thresholds
studied (5.6, 6.1, and 7 mmol/l), POC
glucose appropriately reclassiﬁed the risk
of between 13 and 30% of participants,
ranked according to clinical scores (sup-
plementary Table 3).
There was no evidence of a threshold
clinical score above which undiagnosed di-
abetes was predicted with certainty, while
suchathresholdwasapparentforPOCglu-
cose(Fig.2).Similarly,therewasnothresh-
old to rule out undiagnosed diabetes based
on the clinical scores, while a POC glucose
threshold of 5 mmol/l would identify the
70.6% participants in whom all those with
diabetes (100%) were found (Fig. 2 and
supplementary Table 3).
CONCLUSIONS— Our study of the
utility of POC capillary glucose and rou-
tine clinical variables in predicting undi-
agnosed diabetes in a resource-poor rural
setting has four main ﬁndings. First, as
anticipated there was a strong positive
correlation between venous plasma glu-
cose levels and POC capillary glucose lev-
els. Second, POC capillary glucose
provided a very good discriminatory ca-
pacity for identifying those with undiag-
nosed diabetes. Third, POC capillary
glucose assays performed signiﬁcantly
better than a range of models based on
clinical variables and appropriately re-
classiﬁed the risk of a signiﬁcant propor-
tion of participants ranked according to
clinical risk models. And ﬁnally, adding
clinicalvariablestothePOCcapillaryglu-
cose did not improve its discriminatory
capacity for identifying undiagnosed
diabetes.
WHO currently recommends that di-
abetesbediagnosedbymeasuringvenous
fasting blood glucose. In those individu-
als strongly suspected of having diabetes
but with a normal fasting glucose or im-
paired fasting glycemia, a 75-g oral glu-
cose tolerance test (OGTT) is advocated
(22). These tests are rather complex, re-
quire skilled health care workers and lab-
oratory facilities for the analysis of
samples, and are often not available in
low-resource settings. The POC capillary
glucose test is a more attractive, alterna-
tive diagnostic test and is increasingly be-
ing used for this purpose in remote or
resource-poor areas (22) because it is rel-
atively inexpensive ($2 dollars per test)
and provides immediate test results. Our
data would support the use of a single
POC glucose test for identifying those in-
dividuals with diabetes, however the dis-
criminatory capacity would likely be
improvedbyasecondconﬁrmatoryblood
Table 2—Multivariable association between clinical variables, POC capillary glucose, and presence of diabetes
AUC P* Calibration 
2 (P)† IDI (P)‡
Clinical variables alone
Model 1  age 	 BMI 	 hypertension 0.670 (0.585–0.755) 0.0001 5.67 (0.13) N/A
Model 1 	 waist 0.694 (0.621–0.766) 0.0001 5.73 (0.13) N/A
Model 1 	 hip 0.681 (0.601–0.760) 0.0001 0.79 (0.85) N/A
Model 1 	 WHR 0.680 (0.600–0.760) 0.0001 1.69 (0.64) N/A
Mohan’s diabetes risk score 0.662 (0.581–0.743) 0.0001 7.43 (0.06) N/A
Ramachandran’s diabetes risk score 0.678 (0.597–0.759) 0.0001 0.75 (0.86) N/A
POC glucose alone 0.869 (0.809–0.929) N/A 3.87 (0.28) N/A
Clinical variables 	 POC glucose§
Model 2  Model 1 	 POC glucose 0.867 (0.803–0.932) 0.72 2.11 (0.55) 1.64 (0.04)
Model 2 	 waist 0.868 (0.804–0.932) 0.89 2.14 (0.54) 1.74 (0.02)
Model 2 	 hip 0.875 (0.813–0.937) 0.37 1.32 (0.72) 1.72 (0.04)
Model 2 	 WHR 0.868 (0.803–0.932) 0.74 2.12 (0.55) 1.63 (0.04)
Mohan’s diabetes risk score 	 POC glucose 0.879 (0.819–0.938) 0.24 1.77 (0.63) 0.36 (0.54)
Ramachandran’s diabetes risk score 	 POC glucose 0.874 (0.812–0.935) 0.44 1.83 (0.61) 0.21 (0.62)
WHR,waist-to-hipratio.*ComparedtoAUCofPOCglucosealone.†HosmerandLemeshowcalibration
2testandtheaccompanyingPvalue,basedon5subgroups
of participants and 3 df. ‡IDI and P value comparing POC glucose alone and POC glucose 	 clinical variables. §All P values 0.0001 for AUC comparison between
models with clinical variables alone and the equivalents with POC glucose.
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performance of POC glucose such as pos-
itive and negative predictive value will
varyaccordingtotheprevalenceofdiabe-
tes in different populations, the sensitiv-
ity, speciﬁcity, and AUC would be
expected to remain similar.
Several prior studies have analyzed
the utility of POC capillary glucose as a
diagnostic test with varied results (14–
16). Two of these studies speciﬁcally ex-
amined the utility of POC testing among
high-risk populations (15,16). One study
in the Australian indigenous population
(15) found that POC glucose had good
discriminatorycapacityforpredictingun-
diagnosed diabetes (using fasting venous
glucose as the standard), and the other
study in Maori (16) found that POC glu-
cose had acceptable discriminatory ca-
pacity(usingOGTTasthegoldstandard).
The differing levels of discrimination
achieved may reﬂect diabetes presenting
as fasting hyperglycemia compared with
diabetes presenting as postprandial hy-
perglycemia. In the early stages of diabe-
tes, glucometabolic derangements
primarily affect postprandial glucose lev-
els. Therefore, fasting POC glucose assays
will miss some cases of diabetes that
would be identiﬁed on the basis of a 2-h
glucose assay after an OGTT.
Our data suggest that performing a
POC capillary glucose assay and using a
thresholdlevelof7.0mmol/lwouldresult
in the identiﬁcation of 65% of those with
undiagnosed diabetes. If the threshold
was decreased to 6.1 mmol/l, 
80%
wouldbeidentiﬁed.Reducingthethresh-
old further would detect few additional
cases as the prevalence of undiagnosed
diabetes within the lower strata is very
low (3%).
There has been a lot of recent interest
intheuseofclinicalriskassessmentques-
tionnaires or derived risk scores for de-
tecting undiagnosed diabetes (9–13).
Our study compared the utility of risk as-
sessment based on clinical variables with
POC glucose testing. We found that the
POCglucosetestwasalwaysbetteratpre-
dicting undiagnosed diabetes, and the
combination of a POC glucose test and
clinical risk assessment variables was no
better than POC glucose alone. The per-
formanceoftheriskassessmentquestion-
naire was likely adversely impacted by
poor knowledge of the participants’ med-
ical and family histories and limited ac-
cess to diagnostic facilities. This was
especially evident when considering the
small proportion (13%) of individuals
withnewdiabeteswhohadpreviouslyre-
ported a family history of diabetes. Based
on the epidemiological data from urban
areas in India, the actual prevalence
would be expected to be closer to 40%
(23). The performance of the Indian risk
scores, which were evaluated against 2-h
postprandial glucose criteria, also could
have been underestimated by the lack of
an OGTT in our sample.
Figure 2—Logistic curves showing the predicted and observed probability of undiagnosed diabe-
tes at different levels of POC capillary glucose (A), Mohan’s diabetes risk score (B), and Ram-
achandran’s diabetes risk score (C). For each ﬁgure panel, the curve is for the predicted
probabilityandtheshadedareaisforthe95%CI.Theblackcirclesarefortheobservedprobability
(1.00 for those with undiagnosed diabetes and 0.00 for those without diabetes). Solid horizontal
and vertical lines are added at regular intervals to assist interpretation. Vertical broken lines are
also displayed at the cutoff points of capillary glucose and risk (5.6, 6.1, and 7 mmol/l), Mohan’s
score (60), and Ramachandran’s score (21) used to deﬁne high risk of undiagnosed diabetes.
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dian risk scores in our rural sample were
similar to those reported in the original
urban populations (9,13). Indeed these
tools appear equally useful in rural set-
tings where they would help to direct the
needfordeﬁnitivediagnosticteststoward
the half of the population where three-
quarters of undiagnosed diabetes occurs.
With three-quarters of Indians living
outside cities and increasing rates of diabe-
tes in nonurban populations, the rural na-
tureofthisstudyisakeystrength.Likewise
our extensive analysis that assesses the pre-
dictive accuracy of POC glucose across the
whole range of the measurements in the
sample adds substantively to the evidence
providedbypriorreportsthathaveassessed
diagnosticaccuracyonlyonthebasisofpre-
speciﬁed cutoffs of POC capillary glucose
levels(24).Themainlimitationofthisstudy
is that the diagnosis of diabetes was based
on a single fasting venous glucose measure-
ment. While this may be valid for epidemi-
ological purposes, it is at variance with
routine clinical practice where diabetes is
diagnosed on the basis of two consecutive
samples.
In conclusion, Asian Indians are re-
portinganincreasingprevalenceofdiabe-
tes,butalargeproportionofcasesremain
undiagnosed. WHO has recommended
targeted screening, and our results sup-
port the use of the POC capillary glucose
test for identifying new cases of diabetes
in low-resource rural settings on the In-
dian subcontinent. Studies evaluating the
cost-effectiveness of introducing POC
glucose testing are needed prior to wide-
spread implementation.
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